Loading...
•
Jun 30, 2021
IRadimed Q2 2021 Earnings Report
IRadimed reported record high total bookings and revenue growth trends, overcoming challenges from the past year.
Key Takeaways
IRadimed Corporation announced financial results for Q2 2021, with revenue of $9.8 million compared to $6.8 million for Q2 2020. Net income was $1.5 million, or $0.12 per diluted share, compared to a net loss of $(2.1) million, or $(0.17) per diluted share for Q2 2020. Non-GAAP net income was $1.7 million, or $0.14 per diluted share, compared to $0.6 million, or $0.05 per diluted share for Q2 2020.
Reported revenue of $9.8 million, an increase from $6.8 million in Q2 2020.
Achieved net income of $1.5 million, or $0.12 per diluted share, compared to a net loss of $(2.1) million, or $(0.17) per diluted share in Q2 2020.
Non-GAAP net income reached $1.7 million, or $0.14 per diluted share, compared to $0.6 million, or $0.05 per diluted share in Q2 2020.
Domestic sales accounted for 82.0% of total revenue, compared to 68.3% in Q2 2020.
Revenue by Geographic Location
Forward Guidance
For the third quarter 2021, the Company expects to report revenue of $10.3 million to $10.5 million, GAAP diluted earnings per share of $0.14 to $0.15, and non-GAAP diluted earnings per share of $0.16 to $0.17. For the full year 2021, the Company expects to report revenue of $40.0 million to $40.4 million, GAAP diluted earnings per share of $0.53 to $0.55, and non-GAAP diluted earnings per share of $0.60 to $0.62.
Positive Outlook
- Expects to report revenue of $10.3 million to $10.5 million for Q3 2021.
- GAAP diluted earnings per share of $0.14 to $0.15 for Q3 2021 expected.
- Non-GAAP diluted earnings per share of $0.16 to $0.17 for Q3 2021 expected.
- Expects to report revenue of $40.0 million to $40.4 million for full year 2021.
- GAAP diluted earnings per share of $0.53 to $0.55 for full year 2021 expected.
Challenges Ahead
- Non-GAAP diluted earnings per share guidance excludes stock-based compensation expense, net of tax.
- Stock-based compensation expense expected to be approximately $0.3 million for Q3 2021.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...